Most Alzheimer's disease and nearly half of all dementia was associated with variations in the APOE gene, a study of 470,000 older adults suggested. In all-cause dementia, the two alleles were linked ...
Explore the latest advancements in Alzheimer’s drug research, revealing hope for earlier diagnosis and new treatment options.
Using EEG data from the initial evaluation in older adults reporting only subjective memory concerns, this longitudinal study showed that BrainScope's non-invasive, point-of-care EEG technology can ...
While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating ...
"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...
During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and aid clinical testing.
A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...
Alzheimer’s disease, which represents 60–80% of dementia cases 1, robs people of their memory, cognition and independence. A decade-long period of mild cognitive impairment precedes the onset of ...
Women with Alzheimer's had lower levels of unsaturated lipids, including omega fatty acids, compared with cognitively healthy women. This difference was seen in women but not men, suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results